Antisense oligonucleotides (AONs) designed to specifically induce exon skipping during pre-messenger RNA (pre-mRNA) splicing have shown to be effective in increasing expression of (truncated) dystrophin in a variety of cell and mouse models for Duchenne muscular dystrophy (DMD) [1–9]. Here, DMD is linked to Duchenne muscular dystrophy.